Therapy Areas: Vaccines
South Korea health authority approves Pfizer-19 COVID-19 vaccine for children aged five to 11 years
23 February 2022 -

The food and drug ministry of South Korea has said that the country has approved US pharmaceutical company Pfizer Inc's (NYSE:PFE) COVID-19 vaccine for use with children aged five to 11 years, Reuters news agency reported on Wednesday.

In a statement, the ministry said that children should get one-third of the regular dose, twice with a three week interval.

Children with significantly declined immunity can get a booster four weeks later, the statement added.